Evidence map›Paper›PMID 29259048›Full record

ArticleAnnals of the rheumatic diseases2018

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna

James B Lilleker, Jiri Vencovsky, Guochun Wang, Lucy R Wedderburn, Louise P Diederichsen, Jens Schmidt, Paula Jordan, Olivier Benveniste, Maria Giovanna Danieli, Katalin Dankó and 18 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

James B LillekerDivision of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester, UK.ORCID 0000-0002-9230-4137
Jiri VencovskyInstitute of Rheumatology, Prague, Czech Republic.ORCID 0000-0002-0851-0713
Guochun WangDepartment of Rheumatology, China-Japan Friendship Hospital, Beijing, China.
Lucy R WedderburnUniversity College London GOS Institute of Child Health and NIHR GOSH Biomedical Research Centre, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Louise P DiederichsenDepartment of Rheumatology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-2581-8912
Jens SchmidtDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Paula JordanMyositis UK, Southampton, UK.
Olivier BenvenisteDépartement de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, UPMC, Paris, France.
Maria Giovanna DanieliDipartimento di Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche and Ospedali Riuniti, Ancona, Italy.
Katalin DankóDivision of Immunology, University of Debrecen, Debrecen, Hungary.
Nguyen Thi Phuong ThuyDepartment of Rheumatology, Bach Mai Hospital, Hanoi Medical University, Hanoi, Vietnam.
Monica Vázquez-Del MercadoDivisión de Medicina Interna, Servicio de Reumatología, PNPC 004086, CONACyT, Hospital Civil Dr Juan I Menchaca, Guadalajara, Jalisco, Salvador Quevedo y Zubieta S/N, Guadalajara, Mexico.
Helena AnderssonDepartment of Rheumatology, Oslo University Hospital, Oslo, Norway.
Boel De PaepeDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Jan L De BleeckerDepartment of Neurology, Ghent University Hospital, Ghent, Belgium.
Britta MaurerDepartment of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Liza J McCannDepartment of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Nicolo PipitoneDepartment of Rheumatology, Arcispedale S Maria Nuova-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Neil McHughRoyal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath, Bath, UK.
Zoe BetteridgeRoyal National Hospital for Rheumatic Diseases, Royal United Hospitals Bath, Bath, UK.
Paul NewMRC-ARUK Institute for Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
Robert G CooperMRC-ARUK Institute for Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
William E OllierDivision of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, School of Health Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Janine A LambDivision of Population Health, Health Services Research and Primary Care, Faculty of Biology, Medicine and Health, School of Health Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
Niels Steen KroghZiteLab ApS, Frederiksberg, Denmark.
Ingrid E LundbergUnit of Rheumatology, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
Hector ChinoyRheumatology Department, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Salford, UK.ORCID 0000-0001-6492-1288
all EuroMyositis contributors

Funding

Medical Research Council G0100594Medical Research Council G0600237Medical Research Council G0900753Medical Research Council G0901461Medical Research Council MR/K002279/1Medical Research Council MR/N003322/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MyositisHumansRegistriesResearchdisease activityinflammationtreatment

Identifiers

PMID29259048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.